HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of two strains of L5178Y cells to cis-dichlorobis(cyclopentylamine)platinum(II). I. Cross-sensitivity to cis-PAD and UV light.

Abstract
The response to cis-dichlorobis(cyclopentylamine)platinum(II) (cis-PAD) an antitumour platinum complex, was studied in two strains of murine lymphoma L5178Y cross-sensitive to X-rays and UV light. Dose-survival relationship, DNA synthesis formation of chromatid aberrations, progression through the cell cycle, and growth and viability changes after 1 h cis-PA; treatment at 37 degree C were examined and compared with the effects of X-rays and UV light. In both strains, cis-PAD caused immediate inhibition of progression through the cell cycle, reduced rate of DNA synthesis, delayed appearance of chromatid aberrations, and delayed death; however, there is a marked difference in sensitivity to cis-PAD between L5178Y-S strain (D0 approx. 5.8 microgram/ml) and L5178Y-R strain (D0 approx. 2.5 microgram/ml). In both strains a close resemblance was found between dose-survival relationships after cis-PAD and UV light treatment, respectively.
AuthorsI Szumiel
JournalChemico-biological interactions (Chem Biol Interact) Vol. 24 Issue 1 Pg. 51-72 (Jan 1979) ISSN: 0009-2797 [Print] Ireland
PMID428002 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • DNA, Neoplasm
  • Organoplatinum Compounds
  • dichlorobis(cyclopentylamine)platinum
Topics
  • Animals
  • Cell Cycle (drug effects, radiation effects)
  • Cell Division (drug effects, radiation effects)
  • Cell Survival (drug effects, radiation effects)
  • Chromosome Aberrations
  • DNA, Neoplasm (biosynthesis)
  • L Cells (drug effects, metabolism, radiation effects)
  • Mice
  • Organoplatinum Compounds (pharmacology)
  • Ultraviolet Rays
  • X-Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: